June 11, 2026  -  Investment

Women’s Health Investment Round-up (May 2026)

At the beginning of each month, we look back and share which companies have announced new funding rounds. Below is April 2026’s round-up.

Contraline raises a $92.5M Series B to advance its male contraceptive gel into phase 3.

Signos raises $20M for its FDA-cleared, CGM-based weight management system.

Ilant Health raises $15M to deliver value-based obesity care for health plans and employers.

Media company Just Women's Sports closes seven-figure round.

Oli raises $6.5M to advance predictive maternal and fetal monitoring ahead of market entry.

Gaia secures a $100M debt facility to scale outcome-protected fertility

Australian medtech NinaMED launches with $13.75M to develop a non-invasive wearable for overactive bladder.

UroMems raises $60M for its smart implant to treeat stress urinary incontinence.

BlueWind Medical raises $47.8M to commercialize its implantable neuromodulation device for urgency urinary incontinence.

Autoimmunity BioSolutions raises a $1M seed extension for its genetically targeted autoimmune therapy.

Nourish raises a $100M Series C for its AI-native metabolic health clinci with GLP-1 integration.

Japan-based Flora raises $1.5M to scale its women's health platform across consumer app, corporate wellbeing, and data-driven business development.

India's HealthFab raises $2.4M to expand from period care into broader menstrual wellness.

Omaia closes a pre-seed round for its pregnancy emotions support platform.